Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc.
Athenex Investor Alert: Kaplan Fox Investigates Potential Securities Fraud at Athenex, Inc. Kaplan Fox & Kilsheimer LLP NEW YORK, March 03, 2021 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com) is investigating claims on behalf of investors of Athenex, Inc. (“Athenex” or the “Company”) (NASDAQ: ATNX). On March 1, 2021, Athenex issued a press release reporting its fourth quarter results and disclosing receipt of a complete response letter (“CRL”) from the FDA regarding its new drug application for Oral Paclitaxel Plus Encequidar for the treatment of metast...